Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 1 - 10 of 24 results
-
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Date:
03/01/2025Lead Investigators:
-
Digital iTap
Date:
08/01/2024Topics:
Lead Investigators:
-
Investigating SARS-CoV-2 persistence in human gut organoids
Date:
07/01/2024Topics:
Lead Investigators:
-
Sex, obesity, immunometabolism, and viral persistence in post-acute sequelae of SARS-CoV-2 infection
Date:
07/01/2023Topics:
Lead Investigators:
-
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Date:
06/01/2023Topics:
Lead Investigators:
-
EVOLVE: Emetine for Viral Outbreaks, A Double Blind Randomized Controlled Clinical Trial
Date:
06/01/2023Topics:
Lead Investigators:
-
AZD5156/AZD3152 mAbs for Covid-19 Prophylaxis in Immunocompromised Patients
Date:
01/01/2023Locations:
Lead Investigators:
-
mRNA vaccine responses in PLWH
Date:
08/22/2022Lead Investigators:
-
Sex, obesity, immunometabolism, and viral persistence in post-acute sequelae of SARS-CoV-2 infection
Date:
08/12/2022Lead Investigators:
-
Long-term outcomes of SARS-CoV-2 infections and risk factors of COVID-19 vaccine breakthrough infections in kidney transplant recipients
Date:
07/01/2022Lead Investigators: